Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Julphar
McKesson
Baxter
Cipla
Citi
Daiichi Sankyo
Mallinckrodt

Generated: June 24, 2018

DrugPatentWatch Database Preview

NIRAVAM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Niravam patents expire, and what generic alternatives are available?

Niravam is a drug marketed by Ucb Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has sixteen patent family members in nine countries.

The generic ingredient in NIRAVAM is alprazolam. There are fifteen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Drug patent expirations by year for NIRAVAM
Medical Subject Heading (MeSH) Categories for NIRAVAM
Synonyms for NIRAVAM
08H
12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
12-CHLORO-3-METHYL-9-PHENYL-2,4,5,8-TETRAAZATRICYCLO[8.4.0.0(2),?]TETRADECA-1(10),3,5,8,11,13-HEXAENE
28981-97-7
3u5j
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-(1,2,4)Triazolo(4,3-alpha)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-1-methyl-6-phenyl-
4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
51339-48-1
8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-(phenyl-d5)-4H-(1,2,4)triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine
8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepine
8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-alpha)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
8-chloro-6-phenyl-1-methyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine
981A977
A819702
AC-18721
AC1L1CYL
ACN-036616
AK339386
AKOS005066050
Alcelam
Algad
Alpaz
Alphapharm Brand of Alprazolam
Alplax
Alpram
Alprax
alprazolam
Alprazolam (JP15/USP/INN)
Alprazolam (JP17/USP/INN)
Alprazolam [USAN:INN:BAN:JAN]
Alprazolam [USAN:USP:INN:BAN:JAN]
Alprazolam 0.1 mg/ml in Methanol
Alprazolam 1.0 mg/ml in Methanol
Alprazolam Alphapharm Brand
Alprazolam Apotex Brand
Alprazolam extended release tablets
Alprazolam intensol
Alprazolam Kenral Brand
Alprazolam Novopharm Brand
Alprazolam Nu-Pharm Brand
Alprazolam Orion Brand
Alprazolam Pfizer Brand
Alprazolam solution
Alprazolam solution, 1 mg/mL in methanol, analytical standard, for drug analysis
Alprazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Alprazolam Temmler Brand
Alprazolam, European Pharmacopoeia (EP) Reference Standard
Alprazolamum
Alprazolamum [INN-Latin]
Alprazolan
Alpronax
Alprox
Alviz
Alzam
Alzolam
Alzon
Anpress
AP-1002
API0001427
Apo Alpraz
Apo-Alpraz
ApoAlpraz
Apotex Brand of Alprazolam
Arzneimittelwerk Dresden Brand of Alprazolam
AZ-002
Azor
BBL028160
BC226242
BDBM50001728
Bestrol
BIDD:GT0475
BIDD:PXR0150
Bio-0790
BRD-K32398298-001-01-4
BRN 1223125
C06817
CAS-28981-97-7
Cassadan
CCG-100855
CHEBI:2611
CHEMBL661
Constan
CPD000149316
D 65MT
D-65MT
D00225
D0L9GG
D65MT
DB00404
DEA No. 2882
DR001286
DSSTox_CID_2577
DSSTox_GSID_22577
DSSTox_RID_76639
DTXSID4022577
EINECS 249-349-2
Esparon
Frontal
FT-0658560
Gen-Alprazolan
GTPL7111
Helex
HMS2051A10
HMS3393A10
HSDB 7207
I14-7472
Intensol
Kenral Brand of Alprazolam
Ksalol
LS-156344
MCULE-1215564244
Mialin
MLS000559000
MLS000759485
MLS001423979
NC00105
NCGC00159466-02
NCGC00159466-03
Neurol
Niravam (TN)
Novo Alprazol
Novo-Alprazol
NovoAlprazol
Novopharm Brand of Alprazolam
NSC-760140
NSC760140
Nu Alpraz
Nu Pharm Brand of Alprazolam
Nu-Alpraz
Nu-Pharm Brand of Alprazolam
NuAlpraz
Orion Brand of Alprazolam
Panistat
Panix
Pfizer Brand of Alprazolam
Pharmakon1600-01502395
Pharnax
PL053252
Prazam
Prazolan
Prinox
Ralozam
Relaxol
Restyl
SAM001246696
SCHEMBL8398
SMR000149316
Solanax
Staccato-alprazolam
STK590494
Tafil
Tafil D
Temmler Brand of Alprazolam
Tensivan
TGAR01P
Tox21_111692
Tranax
Trankimazin
Tranquinal
Tricalma
Tus 1
TUS-1
U 31889
U-31,889
U-31889
U31,889
UNII-YU55MQ3IZY
Unilan
Valeans
VREFGVBLTWBCJP-UHFFFAOYSA-N
W-107015
Xanagis
Xanax
Xanax (TN)
Xanax TS
Xanax XR
Xanolam
Xanor
Xanor (TN)
YU55MQ3IZY
Zacetin
Zanapam
Zaxan
ZB000199
Zenax
ZINC903
Zolam
Zolan
Zolarem
Zoldac
Zoldax
Zopax
Zopic
Zotran

US Patents and Regulatory Information for NIRAVAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-001 Jan 19, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-004 Jan 19, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-002 Jan 19, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-004 Jan 19, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for NIRAVAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-002 Jan 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-001 Jan 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-002 Jan 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Ucb Inc NIRAVAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 021726-003 Jan 19, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for NIRAVAM
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Orally Disintegrating Tablets 0.25 mg, 0.5 mg, 1 mg and 2 mg ➤ Subscribe 2005-12-27

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Fuji
Teva
Johnson and Johnson
Cipla
Deloitte
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.